ArticlePloS one2025
Diabetes mellitus and associated factors among psychiatric patients receiving antipsychotic treatment at Wachemo University Nigist Elleni Hospital, South Ethiopia.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes mellitus is one of the most common non-communicable diseases, and its epidemic proportion has placed it at the forefront of public health challenges currently facing the world. Patients with severe mental illnesses who receive antipsychotic treatment have a high risk of developing metabolic disturbances. METHOD AND MATERIAL: A hospital-based cross-sectional study was conducted. A total of 216 psychiatric patients on treatment were included and selected by consecutive convenient sampling techniques. An interviewer-administered questionnaire was used to collect socio-demographic, clinical, and behavioral characteristics. The levels of fasting blood glucose were measured by Cobas 4000 series Cobas c311Basel, Switzerland. The data were entered into Epi data version 4.6 and analyzed by SPSS version 25. Data were summarized by tables, graphs, and descriptive statistics. Bivariate and multivariate logistic regressions were used. P-value <0.05 was considered statistically significant.
resultA total of 216 psychiatric patients were enrolled in this study. The overall prevalence of diabetes mellitus was 25(11.6%). Among participants with diabetes mellitus, the prevalence of diabetes mellitus was higher in females than males (17(68.0%) vs 8(32.0%). Female (AOR:6.483, 95% CI (1.647, 25.516), P- value = 0.007), longer duration of antipsychotic use (AOR: 7.876 (1.587-39.090), moderate physical activity (AOR: 0.220, 95% CI (.057-.85), P- value = 0.028), higher body mass index (11.869, 95% CI (2.188-64.374), P- value = .004), and high cholesterol(AOR:13.742. 95% CI (3.153-59.887), P- value = .000) were significantly associated to diabetes mellitus.
conclusionThe finding of this study revealed that the prevalence of diabetes mellitus was 11.6%. Female sex, longer duration of antipsychotic use, moderate physical activity, overweight BMI, and high total cholesterol were significantly associated. Therefore, Health providers should regularly weigh patients and monitor long-term side effects of medication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.